156 related articles for article (PubMed ID: 32247000)
1. Clinical relevance of Clostridium bacteremia: An 8-year retrospective study.
Stabler S; Titécat M; Duployez C; Wallet F; Loïez C; Bortolotti P; Faure E; Faure K; Kipnis E; Dessein R; Le Guern R
Anaerobe; 2020 Jun; 63():102202. PubMed ID: 32247000
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and outcomes of Clostridium perfringens bacteremia--a 10-year experience at a tertiary care hospital.
Yang CC; Hsu PC; Chang HJ; Cheng CW; Lee MH
Int J Infect Dis; 2013 Nov; 17(11):e955-60. PubMed ID: 23578849
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics associated with mortality of patients with anaerobic bacteremia.
Umemura T; Hamada Y; Yamagishi Y; Suematsu H; Mikamo H
Anaerobe; 2016 Jun; 39():45-50. PubMed ID: 26903282
[TBL] [Abstract][Full Text] [Related]
4. Case of Clostridium perfringens bacteremia after routine colonoscopy and polypectomy.
Kunz AN; Riera D; Hickey P
Anaerobe; 2009 Oct; 15(5):195-6. PubMed ID: 19324098
[TBL] [Abstract][Full Text] [Related]
5. Clostridium perfringens bacteraemia, an analysis of 28 cases over 10 years in a university hospital of Madrid.
Lopez-Fabal MªF; Sanz N; Ruiz-Bastian M; Barros C; Gomez-Garces JL
Enferm Infecc Microbiol Clin (Engl Ed); 2018 Apr; 36(4):225-228. PubMed ID: 28372873
[TBL] [Abstract][Full Text] [Related]
6. Massive intravascular hemolysis from Clostridium perfringens septicemia: a review.
Simon TG; Bradley J; Jones A; Carino G
J Intensive Care Med; 2014; 29(6):327-33. PubMed ID: 24019300
[TBL] [Abstract][Full Text] [Related]
7. Clostridium bacteremia: emphasis on the poor prognosis in cirrhotic patients.
Chen YM; Lee HC; Chang CM; Chuang YC; Ko WC
J Microbiol Immunol Infect; 2001 Jun; 34(2):113-8. PubMed ID: 11456356
[TBL] [Abstract][Full Text] [Related]
8. Clostridium bacteraemia characterised by 16S ribosomal RNA gene sequencing.
Woo PC; Lau SK; Chan KM; Fung AM; Tang BS; Yuen KY
J Clin Pathol; 2005 Mar; 58(3):301-7. PubMed ID: 15735165
[TBL] [Abstract][Full Text] [Related]
9. Anaerobic bacteremia: incidence, patient characteristics, and clinical significance.
Lombardi DP; Engleberg NC
Am J Med; 1992 Jan; 92(1):53-60. PubMed ID: 1731510
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and outcomes of clostridial bacteremia at a tertiary-care institution.
Shah M; Bishburg E; Baran DA; Chan T
ScientificWorldJournal; 2009 Feb; 9():144-8. PubMed ID: 19252754
[TBL] [Abstract][Full Text] [Related]
11. Clostridium perfringens bacteremia. Opportunist or killer?
Nelson RM; Wilson RF; Osmer RL
Am Surg; 1985 Jun; 51(6):301-3. PubMed ID: 2859823
[TBL] [Abstract][Full Text] [Related]
12. The antibiotic susceptibility pattern of gas gangrene-forming
Sárvári KP; Schoblocher D
Infect Dis (Lond); 2020 Mar; 52(3):196-201. PubMed ID: 31778089
[No Abstract] [Full Text] [Related]
13. Clostridium perfringens sepsis following a molar pregnancy.
Adams BN; Lekovic JP; Robinson S
Am J Obstet Gynecol; 2014 Jan; 210(1):e13-4. PubMed ID: 24096275
[TBL] [Abstract][Full Text] [Related]
14. Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study.
Zahar JR; Farhat H; Chachaty E; Meshaka P; Antoun S; Nitenberg G
Clin Microbiol Infect; 2005 Sep; 11(9):724-9. PubMed ID: 16104987
[TBL] [Abstract][Full Text] [Related]
15. A rare case of Clostridium paraputrificum bacteremia in a 78-year-old Caucasian man diagnosed with an intestinal neoplasm.
Intra J; Milano A; Sarto C; Brambilla P
Anaerobe; 2020 Dec; 66():102292. PubMed ID: 33171286
[TBL] [Abstract][Full Text] [Related]
16. Clostridium perfringens bacteremia caused by choledocholithiasis in the absence of gallbladder stones.
Atia A; Raiyani T; Patel P; Patton R; Young M
World J Gastroenterol; 2012 Oct; 18(39):5632-4. PubMed ID: 23112558
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibilities of canine Clostridium difficile and Clostridium perfringens isolates to commonly utilized antimicrobial drugs.
Marks SL; Kather EJ
Vet Microbiol; 2003 Jun; 94(1):39-45. PubMed ID: 12742714
[TBL] [Abstract][Full Text] [Related]
18. Clinical and epidemiological features of Clostridium perfringens bacteremia: a review of 18 cases over 8 year-period in a tertiary care center in metropolitan Tokyo area in Japan.
Fujita H; Nishimura S; Kurosawa S; Akiya I; Nakamura-Uchiyama F; Ohnishi K
Intern Med; 2010; 49(22):2433-7. PubMed ID: 21088344
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of Clostridium species bacteremia in Calgary, Canada, 2000-2006.
Leal J; Gregson DB; Ross T; Church DL; Laupland KB
J Infect; 2008 Sep; 57(3):198-203. PubMed ID: 18672296
[TBL] [Abstract][Full Text] [Related]
20. Massive intravascular hemolysis is an important factor in Clostridium perfringens-induced bacteremia.
Suzaki A; Komine-Aizawa S; Nishiyama H; Hayakawa S
Intern Emerg Med; 2022 Oct; 17(7):1959-1967. PubMed ID: 35962901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
